This led to a significant imbalance in the Bax/Bcl-2 ratio (1.49 ± 0.29-fold increase vs. control set as 1; Figure 1D), indicating a susceptibility of CLL cells to an intrinsic apoptosis pathway. The gene discussed is BCL2; the disease is B-cell chronic lymphocytic leukemia.